Source: Orthopedic Design & Technology

Relievant: Boston Scientific Completes Acquisition of Relievant Medsystems

Relievant offers the FDA-cleared Intracept intraosseous nerve ablation system for vertebrogenic pain.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Tyler Binney's photo - President & CEO of Relievant

President & CEO

Tyler Binney

CEO Approval Rating

82/100

Read more